ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $817,000 | -9.6% | 14,200 | 0.0% | 1.09% | -10.2% |
| Q1 2015 | $904,000 | -0.4% | 14,200 | -3.4% | 1.22% | -4.3% |
| Q4 2014 | $908,000 | +62.4% | 14,700 | +2.1% | 1.27% | +51.2% |
| Q3 2014 | $559,000 | +160.0% | 14,400 | +130.4% | 0.84% | +164.8% |
| Q2 2014 | $215,000 | -68.3% | 6,250 | -60.2% | 0.32% | -70.2% |
| Q1 2014 | $678,000 | -45.3% | 15,700 | -49.5% | 1.07% | -16.5% |
| Q4 2013 | $1,239,000 | +32.2% | 31,100 | +24.6% | 1.28% | +22.9% |
| Q3 2013 | $937,000 | – | 24,950 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |